About the Authors
- Rui-Ru Ji
-
* E-mail: ruiruji@gmail.com
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Heshani de Silva
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Yisheng Jin
-
Affiliation Johnson Graduate School of Management, Cornell University, Ithaca, New York, United States of America
- Robert E. Bruccoleri
-
Affiliation Congenomics, Glastonbury, Connecticut, United States of America
- Jian Cao
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Aiqing He
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Wenjun Huang
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Paul S. Kayne
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Isaac M. Neuhaus
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Karl-Heinz Ott
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Becky Penhallow
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Mark I. Cockett
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Michael G. Neubauer
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Nathan O. Siemers
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
- Petra Ross-Macdonald
-
Affiliation Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America
Competing Interests
The authors are current and previous employees of Bristol-Myers Squibb, who is the manufacturer of dasatinib (one of the compounds included in the study).
Author Contributions
Performed the experiments: HdS JC AH WH BP. Analyzed the data: RRJ YJ KHO PRM. Contributed reagents/materials/analysis tools: RRJ REB PSK IMN MIC NOS. Wrote the paper: RRJ PRM. Developed the analytical methods described in the manuscript: RRJ. Designed the experiments: HdS. Revised the manuscript: YJ REB KHO NOS. Conceived transcriptional dose response concept: MGN.